title: The Role of CT-Based Attenuation Correction and Collimator Blurring Correction in Striatal Spect Quantification.
abstract: Purpose. Striatal single photon emission computed tomography (SPECT) imaging of the dopaminergic system is becoming increasingly used for clinical and research studies. The question about the value of nonuniform attenuation correction has become more relevant with the increasing availability of hybrid SPECT-CT scanners. In this study, the value of nonuniform attenuation correction and correction for collimator blurring were determined using both phantom data and patient data. Methods. SPECT imaging was performed using 7 anthropomorphic phantom measurements, and 14 patient studies using [I-123]-FP-CIT (DATSCAN). SPECT reconstruction was performed using uniform and nonuniform attenuation correction and collimator blurring corrections. Recovery values (phantom data) or average-specific uptake ratios (patient data) for the different reconstructions were compared at similar noise levels. Results. For the phantom data, improved recovery was found with nonuniform attenuation correction and collimator blurring corrections, with further improvement when performed together. However, for patient data the highest average specific uptake ratio was obtained using collimator blurring correction without nonuniform attenuation correction, probably due to subtle SPECT-CT misregistration. Conclusions. This study suggests that an optimal brain SPECT reconstruction (in terms of the lowest bias) in patients would include a correction for collimator blurring and uniform attenuation correction.
authors: Nuclear Medicine, Faculty of Health Sciences, Stellenbosch University and Tygerberg Hospital, Tygerberg, 7505, Cape Town, South Africa.
authors: J M
authors: JM
authors: Warwick
authors: S
authors: S
authors: Rubow
authors: M
authors: M
authors: du Toit
authors: E
authors: E
authors: Beetge
authors: P
authors: P
authors: Carey
authors: P
authors: P
authors: Dupont
references: Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1330-3
references: 18523768
references: Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):BP30-5
references: 12436496
references: Q J Nucl Med Mol Imaging. 2007 Jun;51(2):194-203
references: 17220822
references: Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):443-50
references: 19838702
references: Nucl Med Commun. 1999 Feb;20(2):159-65
references: 10088165
references: J Nucl Med Technol. 1999 Jun;27(2):117-22
references: 10353108
references: Synapse. 2008 Jan;62(1):62-9
references: 17960766
references: Phys Med Biol. 2006 Mar 7;51(5):1269-82
references: 16481693
references: J Nucl Med. 1998 Oct;39(10):1719-26
references: 9776276
references: Nucl Med Commun. 2006 Oct;27(10):765-72
references: 16969257
references: Eur J Nucl Med. 2001 Jan;28(1):90-8
references: 11202457
references: Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):495-502
references: 16435116
references: J Nucl Med. 2003 Jul;44(7):1184-93
references: 12843235
references: Nucl Med Commun. 2005 Dec;26(12):1131-7
references: 16264362
references: Nuklearmedizin. 2004 Dec;43(6):185-9
references: 15586213
references: Neuroimage. 2010 May 1;50(4):1511-8
references: 20083205
references: J Nucl Med. 2000 Feb;41(2):220-7
references: 10688103
references: IEEE Trans Med Imaging. 2002 Aug;21(8):867-77
references: 12472260
references: J Nucl Med. 2005 Sep;46(9):1497-504
references: 16157533
references: IEEE Trans Med Imaging. 1994;13(4):601-9
references: 18218538
references: Phys Med Biol. 1994 Mar;39(3):509-30
references: 15551595
references: J Nucl Med. 1998 Jan;39(1):190-7
references: 9443760
references: Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):23-35
references: 19618181
references: Behav Neurol. 2000;12(4):191-200
references: 11568431
references: Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1334-42
references: 18335217
references: Radiat Med. 2002 Jul-Aug;20(4):187-90
references: 12296434
references: Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1322-9
references: 12845485